Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Oncology Institute (DFPH) Intangibles (2020 - 2025)

Historic Intangibles for Oncology Institute (DFPH) over the last 6 years, with Q3 2025 value amounting to $11.7 million.

  • Oncology Institute's Intangibles fell 2471.28% to $11.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.7 million, marking a year-over-year decrease of 2471.28%. This contributed to the annual value of $14.8 million for FY2024, which is 1728.11% down from last year.
  • According to the latest figures from Q3 2025, Oncology Institute's Intangibles is $11.7 million, which was down 2471.28% from $12.4 million recorded in Q2 2025.
  • In the past 5 years, Oncology Institute's Intangibles ranged from a high of $19.4 million in Q2 2022 and a low of $11.7 million during Q3 2025
  • For the 5-year period, Oncology Institute's Intangibles averaged around $16.7 million, with its median value being $17.4 million (2022).
  • As far as peak fluctuations go, Oncology Institute's Intangibles dropped by 20.12% in 2023, and later crashed by 2471.28% in 2025.
  • Oncology Institute's Intangibles (Quarter) stood at $18.2 million in 2021, then decreased by 1.58% to $18.0 million in 2022, then fell by 0.3% to $17.9 million in 2023, then fell by 17.28% to $14.8 million in 2024, then dropped by 20.78% to $11.7 million in 2025.
  • Its Intangibles stands at $11.7 million for Q3 2025, versus $12.4 million for Q2 2025 and $14.0 million for Q1 2025.